Skip to main content
Caplight Logo









BlueCare Discovery

BlueCare Discovery

Private
NantesHealthcare & Life Scienceshttps://bc-discovery.com

Last Round

VC Round

Mar 1, 2025

Company Overview

BlueCare Discovery is a biotechnology company that develops bioactive compounds from microalgae to prevent and treat neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Application

Keywords

neurodegenerative diseasedrug discoveryAI drug discoverymarine microalgaebioactive compound discoverybiotechdrug discovery platformneuroprotective therapypreclinical drug developmentAlzheimer's therapyfirst-in-class therapeuticsdeep techbiomimicrynutraceuticalsdermocosmeticsanimal health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BlueCare Discovery Comparables

Compare BlueCare Discovery with similar companies based on industry and business-model similarity.

BlueCare Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perha Pharmaceuticals
83%
Nevrargenics Ltd
78%
Sea4Us
73%

BlueCare Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2025
SeedSep 15, 2022

Key People

Founding team and executive leadership

Benoît Serive

Founder, CEO

Founding Team

Hervé Jullien

Advisor to the CEO

Executive Team

BlueCare Discovery Investors

Notable investors and investment history

BlueCare Discovery investors
InvestorRounds
Imagination MachineSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    $1.08M raised in a VC Round.

  • Nov 11, 2024

    Monthly visitors increased 127% MoM.

BlueCare Discovery Filings

Explore SEC and related filing metadata, where available.

BlueCare Discovery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BlueCare Discovery's valuation, stock price, and market status.

Is BlueCare Discovery a public or private company?

BlueCare Discovery is a private company.

What is the current stock price of BlueCare Discovery?

BlueCare Discovery is a private company with no public stock price. No recent secondary market data is available.

How much is BlueCare Discovery worth (valuation)?

Valuation information for BlueCare Discovery is not publicly available.

Can I buy BlueCare Discovery stock?

BlueCare Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BlueCare Discovery's last funding round?

Funding round information for BlueCare Discovery is not publicly available.

Who are the main investors in BlueCare Discovery?

Investor information for BlueCare Discovery is not publicly disclosed.

Will BlueCare Discovery IPO soon?

No public IPO plans have been announced for BlueCare Discovery.

How can I track BlueCare Discovery secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BlueCare Discovery's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNantes
Employee Range3
Year Founded2022
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?